Filling the need for trusted information on national health issues
This brief provides new data from the 2020 KFF Women’s Health Survey on how workplace benefits and caring for children’s health care needs differ by gender and among different subpopulations of women.
This brief presents new data from the KFF Women’s Health Survey on coverage and use of reproductive and sexual health services among different subgroups of women ages 18 to 49.
This brief presents findings from the 2020 KFF Women’s Health Survey on women’s use of health care services, costs, and experiences accessing health care. The 2020 survey is a nationally representative survey of 3,661 women ages 18 to 64, conducted between November 19 and December 17, 2020.
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 7.2 million confirmed cases and 411,000 confirmed deaths worldwide. There have been nearly 2 million confirmed cases and 112,000 confirmed deaths in the United States.
This summarizes the additional federal funding that has been given to health care providers to help them cope with the economic impact of the pandemic and also discusses the latest trends in health care spending.
With supply having increased significantly and eligibility fully open to adults in all states as of April 19, this analysis estimates that COVID-19 vaccine supply will exceed demand across the U.S. over the next 2 to 4 weeks.
This issue brief places the American Jobs Plan in the context of current Medicaid HCBS spending and considers how policymakers might allocate the new funding, as the proposal to date includes little detail.
Explore state-level data on a variety of COVID-19 metrics, including the latest hotspots, cases and deaths by race and ethnicity and at long-term care facilities. Find up-to-date information on state policy actions on social distancing measures and reducing barriers to COVID-19 testing and treatment.
In response to COVID-19, all 50 states + DC are using emergency waivers and other authorities to make changes to their Medicaid programs. Check out details of these Medicaid emergency authorities on our tracker.
A new KFF analysis finds that a relatively small share of drugs, mainly those without generic or biosimilar competitors, accounted for a disproportionate share of prescription drug spending in Medicare in 2019. This finding suggests that recent proposals that focus on prices for a limited number of high-cost drugs could…
